Ignite Creation Date:
2024-05-06 @ 10:01 AM
Last Modification Date:
2024-10-26 @ 12:23 PM
Study NCT ID:
NCT03130582
Status:
COMPLETED
Last Update Posted:
2017-04-28
First Post:
2017-04-22
Brief Title:
High-dose Etoposide Could Discriminate Patients With RefractoryRelapsed Lymphoma Benefit From APBSCT
Sponsor:
Yang Jun
Organization:
Shanghai General Hospital Shanghai Jiao Tong University School of Medicine
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
Keywords:
| Name | View |
|---|---|
| high-dose etoposideautologous peripheral blood stem cell transplantation | View |